These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
368 related items for PubMed ID: 18534634
21. Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha. LoVerme J, Russo R, La Rana G, Fu J, Farthing J, Mattace-Raso G, Meli R, Hohmann A, Calignano A, Piomelli D. J Pharmacol Exp Ther; 2006 Dec; 319(3):1051-61. PubMed ID: 16997973 [Abstract] [Full Text] [Related]
22. Antinociceptive effects of meptazinol and its isomers on carrageenan-induced thermal hyperalgesia in rats. Wang PF, Zhang YQ, Qiu ZB, Zhao ZQ. Sheng Li Xue Bao; 2004 Jun 25; 56(3):295-300. PubMed ID: 15224140 [Abstract] [Full Text] [Related]
23. Fatty acid amide hydrolase (FAAH) inhibition reduces L-3,4-dihydroxyphenylalanine-induced hyperactivity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned non-human primate model of Parkinson's disease. Johnston TH, Huot P, Fox SH, Wakefield JD, Sykes KA, Bartolini WP, Milne GT, Pearson JP, Brotchie JM. J Pharmacol Exp Ther; 2011 Feb 25; 336(2):423-30. PubMed ID: 20966038 [Abstract] [Full Text] [Related]
24. Interference with acute nausea and anticipatory nausea in rats by fatty acid amide hydrolase (FAAH) inhibition through a PPARα and CB1 receptor mechanism, respectively: a double dissociation. Rock EM, Limebeer CL, Ward JM, Cohen A, Grove K, Niphakis MJ, Cravatt BF, Parker LA. Psychopharmacology (Berl); 2015 Oct 25; 232(20):3841-8. PubMed ID: 26297326 [Abstract] [Full Text] [Related]
26. Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide. Loría F, Petrosino S, Mestre L, Spagnolo A, Correa F, Hernangómez M, Guaza C, Di Marzo V, Docagne F. Eur J Neurosci; 2008 Aug 25; 28(4):633-41. PubMed ID: 18657182 [Abstract] [Full Text] [Related]
30. Cyclooxygenases 1 and 2 contribute to peroxynitrite-mediated inflammatory pain hypersensitivity. Ndengele MM, Cuzzocrea S, Esposito E, Mazzon E, Di Paola R, Matuschak GM, Salvemini D. FASEB J; 2008 Sep 25; 22(9):3154-64. PubMed ID: 18497304 [Abstract] [Full Text] [Related]
31. Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy. Nasirinezhad F, Jergova S, Pearson JP, Sagen J. Neuropharmacology; 2015 Aug 25; 95():100-9. PubMed ID: 25486617 [Abstract] [Full Text] [Related]
32. The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomy. Slusar JE, Cairns EA, Szczesniak AM, Bradshaw HB, Di Polo A, Kelly ME. Neuropharmacology; 2013 Sep 25; 72():116-25. PubMed ID: 23643752 [Abstract] [Full Text] [Related]
33. Reducing endocannabinoid metabolism with the fatty acid amide hydrolase inhibitor, URB597, fails to modify reinstatement of morphine-induced conditioned floor preference and naloxone-precipitated morphine withdrawal-induced conditioned floor avoidance. McCallum AL, Limebeer CL, Parker LA. Pharmacol Biochem Behav; 2010 Oct 25; 96(4):496-500. PubMed ID: 20643159 [Abstract] [Full Text] [Related]
38. The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model. Mecs L, Tuboly G, Nagy E, Benedek G, Horvath G. Anesth Analg; 2009 Oct 25; 109(4):1297-304. PubMed ID: 19762760 [Abstract] [Full Text] [Related]
39. The novel reversible fatty acid amide hydrolase inhibitor ST4070 increases endocannabinoid brain levels and counteracts neuropathic pain in different animal models. Caprioli A, Coccurello R, Rapino C, Di Serio S, Di Tommaso M, Vertechy M, Vacca V, Battista N, Pavone F, Maccarrone M, Borsini F. J Pharmacol Exp Ther; 2012 Jul 25; 342(1):188-95. PubMed ID: 22514334 [Abstract] [Full Text] [Related]